|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8560 EUR | -4.36% |
|
-2.49% | -36.80% |
| 06-18 | AB Science Secures US Patent for Prostate Cancer Therapy | MT |
| 06-18 | AB Science Secures New U.S. Patent for Masitinib |  |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 1.61M | 958K | 970K | 1.07M | 1.17M | |||||
Total Assets | 21.27M | 23.84M | 25.5M | 23.18M | 24.52M | |||||
Interest Expense | -23K | -823K | -1.53M | -1.12M | -1.27M | |||||
Income Tax Expense | 36K | 4K | - | - | - | |||||
CAPEX | -564K | -644K | -345K | -155K | -282K | |||||
EBT | -14.43M | -13.61M | -11.98M | -7.83M | -1.56M | |||||
D&A | 886K | 805K | 990K | 671K | 258K | |||||
Operating Income | -13.81M | -15.94M | -13.43M | -6.08M | 639K | |||||
Net Income | -14.46M | -13.62M | -11.98M | -7.83M | -1.56M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | - | - | - | - | 955K | |||||
outside Europe | - | - | - | - | 219K |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Financials AB Science
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
